- Home
- FTDR vs ALKS Comparison
FTDR vs ALKS Comparison
Compare FTDR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTDR | ALKS |
|---|---|---|
| Founded | 1971 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.7B |
| IPO Year | 2018 | 1991 |
Fundamental Metrics
Financial Performance| Metric | FTDR | ALKS |
|---|---|---|
| Price | $60.40 | $29.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $59.75 | $42.85 |
| AVG Volume (30 Days) | 578.6K | ★ 1.6M |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.41 | 2.44 |
| EPS | ★ 3.46 | 2.02 |
| Revenue | ★ $2,042,000,000.00 | $1,521,338,000.00 |
| Revenue This Year | $15.25 | N/A |
| Revenue Next Year | $5.74 | $24.22 |
| P/E Ratio | $16.90 | ★ $14.55 |
| Revenue Growth | ★ 11.77 | 1.08 |
| 52 Week Low | $35.61 | $25.17 |
| 52 Week High | $70.14 | $36.45 |
Technical Indicators
Market Signals| Indicator | FTDR | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 67.71 | 56.99 |
| Support Level | $56.40 | $27.50 |
| Resistance Level | $59.31 | $28.63 |
| Average True Range (ATR) | 1.41 | 0.74 |
| MACD | 0.28 | 0.18 |
| Stochastic Oscillator | 100.00 | 73.26 |
Price Performance
Historical ComparisonAbout FTDR Frontdoor Inc.
Frontdoor Inc is a United States-based company that provides home service plans. It owns multiple home service brands including American Home Shield, HSA, OneGuard, and Landmark brands. Through its home service plans, the company helps its customers maintain their homes and protect against costly and unexpected breakdowns of essential home systems and appliances.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.